Scarica l'app Stockscreener
78.50
0.32%
0.25
Solventum Corp Borsa (SOLV) Ultime notizie
Solventum Named a Best Company to Work for by U.S. News & World Report - Stock Titan
How Did Solventum Corporation's (NYSE:SOLV) 12% ROE Fare Against The Industry? - Yahoo Finance
With 68% ownership, Solventum Corporation (NYSE:SOLV) boasts of strong institutional backing - simplywall.st
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum - Yahoo Finance
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization - PR Newswire
Legacy and innovation on show as Solventum unveils new products - Dentistry UK
Keybanc Initiates Coverage of Solventum (BIT:1SOLV) with Sector Weight Recommendation - Nasdaq
Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & ConsumablesDiversified Stocks - MSN
Keybanc Initiates Coverage of Solventum (SOLV) with Sector Weight Recommendation - Nasdaq
Keybanc Initiates Coverage of Solventum (LSE:0AD1) with Sector Weight Recommendation - Nasdaq
KeyBanc Initiates Solventum at Sector Weight - MarketScreener
Solventum initiated with a Sector Weight at KeyBanc - TipRanks
KeyBanc initiates Solventum stock with Sector Weight rating - Investing.com India
KeyBanc initiates Solventum stock with Sector Weight rating By Investing.com - Investing.com South Africa
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now? - MSN
Solventum to Participate in the 2025 Goldman Sachs Health Care Conference - Kilgore News Herald
Solventum to Participate in the 2025 Goldman Sachs Health Care C - GuruFocus
Solventum Stock Earns RS Rating Upgrade - Investor's Business Daily
Ensemble and Solventum to launch autonomous coding solution for hospitals - MSN
Solventum Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Ameriprise Financial Inc. Boosts Stake in Solventum Co. (NYSE:SOLV) - Defense World
Piper Sandler Upgrades Solventum (BIT:1SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (LSE:0AD1) - Nasdaq
Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI - The Manila Times
Piper Sandler Upgrades Solventum (BMV:SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (SOLV) - Nasdaq
Assessing Solventum: Insights From 9 Financial Analysts - Benzinga
Piper Sandler raises Solventum stock to Overweight, target to $87 By Investing.com - Investing.com Nigeria
Piper Sandler raises Solventum stock to Overweight, target to $87 - Investing.com
Piper Sandler Upgrades Solventum to Overweight From Neutral, Adjusts Price Target to $87 From $78 - marketscreener.com
Solventum upgraded to Overweight from Neutral at Piper Sandler - TipRanks
Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation - TipRanks
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - MSN
Solventum's (NYSE:SOLV) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
Solventum's (NYSE:SOLV) Problems Go Beyond Weak Profit - Yahoo Finance
Solventum Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
People moves: Linda Pazin joins Solventum and Mitch Haws moves to Semtech - IR Impact
Solventum To Present At BofA Securities Health Care Conference; Webcast At 5:20 PM ET - Nasdaq
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
Solventum’s projected $100M tariff hit prevents earnings increase - MedTech Dive
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - MSN
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
0.08%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):